These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23675927)

  • 1. Oseltamivir use in adolescents and adults: clinical and economic considerations.
    Yin JK; Heron L; Salkeld G; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):53-8. PubMed ID: 23675927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir for control of influenza at mass gatherings.
    Tashani M; Rashid H; Ridda I; Heron L; Memish ZA; Haworth E; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):46-52. PubMed ID: 23675926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.
    Karadag-Oncel E; Ceyhan M
    Infect Disord Drug Targets; 2013 Feb; 13(1):15-24. PubMed ID: 23675923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
    Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
    N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P; Jackson R; Cooper K; Rees A; Simpson E; Read R; Nicholson K
    Health Technol Assess; 2009 Feb; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir for the treatment of H1N1 influenza during pregnancy.
    Beigi RH; Pillai VC; Venkataramanan R; Caritis SN
    Clin Pharmacol Ther; 2015 Oct; 98(4):403-5. PubMed ID: 26108913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influenza A, pregnancy and neuraminidase inhibitors].
    Montané E; Lecumberri J; Pedro-Botet ML
    Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir in the management of influenza.
    Oxford J
    Expert Opin Pharmacother; 2005 Nov; 6(14):2493-500. PubMed ID: 16259580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.